ATS Governance

HomeAboutATS Governance ▶ ATS Leadership
ATS Leadership

The ATS installed new officers to lead the Society for the 2017-18 term. Each officer was sworn into a new position on Tuesday, May 23, during the ATS 2017 Plenary Session.

 

Marc Moss, MD

Marc Moss, MD, was installed as president. He will serve as ATS president from 2017 to 2018. Dr. Moss is the Roger S. Mitchell Professor of Medicine in the Division of Pulmonary Sciences and Critical Care Medicine at the University of Colorado School of Medicine.

For more than 14 consecutive years, Dr. Moss has received continuous NIH funding as a principal investigator, and his research has been published in high-impact journals. Before heading up critical care medicine in Colorado, he studied the effects of alcohol abuse on ARDS and performed other collaborative critical care research for 11 years at Emory University in Atlanta.

He is a member of the Planning Committee and will co-chair the Audit and Finance Committee. He also serves on the ATS Foundation Board of Trustees. An ATS member since 1993, Dr. Moss has previously served on multiple ATS committees, including the International Conference, Communications and Marketing, Clinicians Advisory, Program and Budget, Awards, Nominating, and the Education Committees. He has also been a member of several Critical Care Assembly committees, ATS task forces, and the Board of Directors for four terms as a presidential appointee.

During his term as chair of the Communications and Marketing Committee, he helped develop the ATS tagline “We help the world breathe.” As chair of the International Conference Committee, he helped to implement the acceptance of case reports, pairing of junior and senior investigators to serve as co-facilitators for thematic poster sessions, enhancement of poster discussion sessions, and institution of late-breaking abstract submissions.

2016 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: No commercial interests within the past three years that could be considered relevant to ATS activities.

 
Polly Parsons

Polly Parsons, MD, was installed as president-elect for the 2017-18 term, and she will serve as president for the 2018-19 term. Dr. Parsons is the E.L. Amidon Professor and chair of the department of medicine at the University of Vermont.

A member of the ATS since 1989, Dr. Parsons is currently a member of the Members in Transition and Training Committee and has previously been a member of the Nominating, Finance, Publications Policy, Clinicians Advisory, Membership, Assembly on Critical Care Planning, and Program and Budget committees. She was also a chairman of the Training Committee from 2005 to 2006 and currently serves on the editorial board of the  American Journal of Respiratory and Critical Care Medicine. 

In addition to her involvement with the ATS, Dr. Parsons is a member of the NHLBI Scientific Advisory Council. She also represented the ATS in the Multisociety Task Force for Critical Care Research and served as president of the Association of Pulmonary and Critical Care Medicine Program Directors, chair of the Education Committee for the Association of the Professors of Medicine, and chair of the Multisociety Task Force on Competencies in Pulmonary and Critical Care Medicine.

2016 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: No commercial interests within the past three years that could be considered relevant to ATS activities.

 
Jim Beck

James Beck, MD, was installed as vice-president for the 2017-18 term, and he will serve as president for the 2019-20 term. Dr. Beck is Chief of Medicine for the VA Eastern Colorado Health Care System, Professor of Medicine in the Division of Pulmonary Sciences and Critical Care at the University of Colorado, and Vice-Chair for Veterans Affairs in the University of Colorado’s Department of Medicine.

The ATS has been a major component of Dr. Beck’s professional identity since 1987. He has served as MTPI Assembly Chair, Chair of the International Conference and Education Committees, as well as the Chair of the Planning and Evaluation Committee, and Finance Committee. He helped co-lead efforts to create a home for clinician-educators, assisting in the transition to a new Section on Medical Education.

His research interests include HIV-related opportunistic infections and the emerging field of lung microbiome research. Most recently, he was a Principal Investigator for the NHLBI’s Lung HIV Microbiome Project. Dr. Beck’s clinical achievements have been recognized by selection for Best Doctors in America annually since 1994. He is passionate about resident and fellow education and was elected to the University of Colorado’s Academy of Medical Educators in 2014.

2016 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: No commercial interests within the past three years that could be considered relevant to ATS activities.

 
Juan Celedon

Juan C. Celedón, MD, DrPH, was elected as secretary-treasurer for the 2017-18 term, and he will serve as president for the 2020-21 term.

Dr. Celedón is the Niels K. Jerne Professor of Pediatrics and Medicine, and chief of the Division of Pediatric Pulmonary Medicine, Allergy and Immunology at the University of Pittsburgh School of Medicine.

Dr. Celedón earned a degree in medicine from Javeriana University in Colombia and a doctoral degree in public health from Harvard University. He completed a residency in Internal Medicine at Beth Israel Medical Center in New York, a Fellowship in Pulmonary and Critical Care Medicine at Brown University, and a Research Fellowship at the Channing Laboratory of Brigham and Women’s Hospital and Harvard Medical School. In 2000, he joined the faculty at Harvard Medical School, rising to Associate Professor before joining the University of Pittsburgh in 2010.

Dr. Celedón’s research has focused on asthma, COPD, and health disparities in airway diseases. His scientific contributions have been acknowledged through the ATS Recognition Award for Scientific Accomplishments, among other honors. A devoted mentor, he was the first faculty member to ever receive both the Young Mentor Award and the A. Clifford Barger Excellence in Mentoring Award from Harvard Medical School.

The ATS has long been his professional home, and his vision for the Society is one of constant innovation and excellence in diversity.

2016 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: No commercial interests within the past three years that could be considered relevant to ATS activities.

 
David Gozal, MD

David Gozal, MD, MBA, was installed as immediate past president.  Dr. Gozal is the Herbert T. Abelson professor in the Department of Pediatrics at the University of Chicago. He chairs the Finance Committee, serves as a non-voting member of the Council of Chapter Representatives, and is a member of all committees except the Nominating Committee.

An ATS Member since 1991, Dr. Gozal was honored as a 2002 Amberson Lecturer and delivered the presentation “Neurobehavioral Deficits of Sleep-Disordered Breathing: Evidence For Developmentally-Regulated Brain Injury, Inflammation and Repair.” He’s a member of the Assemblies of Sleep Respiratory & Neurobiology and Pediatrics and had served on the ATS Board of Directors as chair of the SRN (then RNS) from May 2001 to June 2003, and also served in the Planning and Evaluation and Health Policy Committees, and on the SRN Assembly Planning Committee. He also served as an associate editor of the American Journal of Respiratory and Critical Care Medicine.

Before joining the University of Chicago in 2009, Dr. Gozal established the Division of Pediatric Sleep Medicine and the Sleep Medicine Fellowship Program at the University of Louisville, and had also taught at Tulane University, University of California Los Angeles, and University of Southern California. Early in his career, Dr. Gozal helped to develop rural health care networks in Cameroon, West Africa, and was honored as a "Knight of the Order of Merit" of Cameroon.

2016 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: No commercial interests within the past three years that could be considered relevant to ATS activities.

Last Reviewed: June 2017